Back to search
FDAFDA · Food and drugs·Recall number Z-2401-2026

Bicarby Dialysate; Model number: RFP-400-G;

Published June 17, 2026 · Recall initiated: May 7, 2026

Summary

FDA records medical device Class II recall Z-2401-2026, published June 17, 2026 and initiated May 7, 2026. Recalling firm: Fresenius Medical Care Holdings, Inc.; Status: Ongoing; Reported quantity: 4752; Lot: Model number: RFP-400-G; UDI-DI: 00840861102839; Lot codes: 25SG06026, 25SG06027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

There is an error in the labeling of the GTIN on the product. When scanned; however, the case labeling, lot number, and printed labeling on the product correctly identifies the product code and the solution contained in the bag. In the event the incorrect GTIN labeling is used as the singular source for product identification, unrecognized use of a potassium solution with a concentration differing from the prescription may result.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fresenius Medical Care Holdings, Inc.
Distributor
Domestic: TX.
Lot
Model number: RFP-400-G; UDI-DI: 00840861102839; Lot codes: 25SG06026, 25SG06027;
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Bicarby Dialysate; Model number: RFP-400-G; recalled?

Yes. FDA published recall Z-2401-2026 on June 17, 2026. Reported hazard: There is an error in the labeling of the GTIN on the product. When scanned; however, the case labeling, lot number, and printed labeling on the product correctly identifies the product code and the solution contained in the bag. In the event the incorrect GTIN labeling is used as the singular source for product identification, unrecognized use of a potassium solution with a concentration differing from the prescription may result.

What should I do if I have this product?

Voluntary: Firm initiated · Letter